| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1a9dad7f805a92156b0b984bcf293f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3039c826e0b5b5af7cbf15459e4ae763 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-583 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6433d65d2369fa57d55efdce0e7377a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c584ec6814d2c85e5494b0088a7a022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f07445f8344ff8205e3fa1b00a8a612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_385679d5c706833b9d4248698410961b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_675114fc6783f8182177120042380393 |
| publicationDate |
2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112114149-A |
| titleOfInvention |
Application of receptor reagent in diagnosis of myocardial damage of main body |
| abstract |
The present invention relates to the use of a receptor reagent for the preparation of a kit for use in a method for in vitro diagnosing whether a subject has myocardial damage, wherein the method comprises: contacting body fluid from a subject with an acceptor reagent and a donor reagent, and generating a mixture to be tested after reaction; exciting the mixture to be detected at least once with excitation light, and detecting the signal intensity of chemiluminescence generated thereby; quantitatively calculating the concentration of at least one myocardial marker in the body fluid according to the signal intensity of the chemiluminescence, thereby judging whether the subject suffers from myocardial damage; the acceptor reagent comprises acceptor particles which can react with active oxygen to generate chemiluminescence, and the variation coefficient C.V of the particle size distribution of the acceptor particles in the acceptor reagent is controlled to be more than or equal to 5%; the donor agent comprises donor particles capable of generating reactive oxygen species in an excited state. The method has ultrahigh sensitivity and wide detection range. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113092789-A |
| priorityDate |
2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |